CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

AI can deliver gains of $21m per drug development programme, study finds

Positive
AI Analysis

Summary

A study finds AI adoption in clinical trial workflows can generate $21 million in gains per drug development program. The analysis highlights increasing use of AI to accelerate drug development processes.

Importance:2/10
Sentiment:
0.40
AIdrug developmentclinical trialscost savings

Read the original article

Published by Clinical Trials Arena on August 13, 2026 2:43 PM

Read Original